Skip to main content
TipRanks
Go Ultimate75% OFF

Synmosa Biopharma Corp (4114) Cash flow

Synmosa Biopharma Corp Cash Flow

TW:4114's free cash flow for Q2 2026 was NT$-144.57M. For the 2026 fiscal year, TW:4114's free cash flow was decreased by NT$-50.64M and operating cash flow was NT$-93.93M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 411.57MNT$ 780.62MNT$ 511.93MNT$ 630.25MNT$ 454.86M
NT$ -663.53MNT$ -336.80MNT$ -717.87MNT$ -69.33MNT$ 73.33M
NT$ 964.20MNT$ -187.55MNT$ 37.24MNT$ -347.94MNT$ -297.57M
NT$ 1.89BNT$ 1.19BNT$ 918.56MNT$ 1.09BNT$ 868.17M
NT$ 130.44MNT$ 510.97MNT$ 242.16MNT$ 445.92MNT$ 312.74M

Currency in TWD

Synmosa Biopharma Corp Cash Flow

-1B-500M0500M1B1.5B2019202020212022202320242025OperatingInvestingFinancing